[{"Assets_0_Q1_USD":101490000.0,"CommonStockSharesOutstanding_0_Q1_shares":42836978.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-19386000.0,"NetIncomeLoss_1_Q1_USD":-17124000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":42251292.0,"StockholdersEquity_0_Q1_USD":25648000.0,"EarningsPerShareBasic_1_Q1_USD":-0.41,"Ticker":"OCUL","CIK":"1393434","name":"OCULAR THERAPEUTIX, INC","OfficialName":"Ocular Therapeutix Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"305481557.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190510"}]